Integra LifeSciences Holdings Corp. said Sept. 22 that it appointed Dr. Raymond Turner as corporate vice president and chief medical officer.
Turner will lead worldwide medical affairs and clinical development activities including clinical research, clinical trial operations, evidence generation, medical safety and communications. In addition to his role with Integra, he will continue his clinical practice, providing patients with neurosurgical care.
“Dr. Turner’s extensive medical and clinical experience and expertise will be significant assets to Integra as we strengthen our focus on building robust clinical evidence,” said Mojdeh Poul, president and chief executive officer, Integra LifeSciences. “His proven leadership and passion for advancing safety and quality will help us continue to deliver innovative solutions and transform patient care.”
Prior to joining Integra, Turner held various leadership roles at Siemens Healthineers, including his most recent position as the chief medical officer for Siemens Endovascular Robotics. Before that, he was a medical director for Cerenovus, a Johnson & Johnson medtech company.
Additionally,Turner served as the program director of the neurosurgery residency program and was the chief of neuroscience (neurological surgery, neurology, and ENT) at the Medical University of South Carolina.
“I am excited to be joining Integra, an organization deeply committed to providing best-in-class, evidence-based products that help restore patient lives,” said Turner. “I look forward to working closely with both the Integra team and our health-care partners to improve patient outcomes and uphold the highest standards of care.”
